+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brachytherapy Market Size, Share & Trends Analysis Report By Dosage Type, By Product (Seeds, Electronic Brachytherapy), By Application (Prostate Cancer, Breast Cancer), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 4751824
Description Jump to:
The global brachytherapy market size is expected to reach USD 1.62 billion by 2030, growing at 7.1% CAGR from 2023 to 2030. The growth of the market is largely attributable to the rising prevalence of cancer, technology advancements, and increasing investment in R&D by major players.

According to the American Cancer Society, in the U. S., 609,360 died due to cancer, and an estimated 1.9 million new cases were recorded in 2022. This is expected to increase to 24.6 million by the year 2030. This is expected to be a major factor driving the growth of the market. Additionally, technological advancements and favorable reimbursement scenarios, particularly in developed countries, are expected to drive market growth.

Some of the key players operating in the brachytherapy industry are ELEKTA AB; Varian Medical Systems; C. R. BARD, Inc.; Eckert & Ziegler BEBIG S. A.; and IsoRay Medical, Inc. Elekta offers targeted and precise treatment for breast, rectum, prostate, skin, surface, and gynecological cancers. Flexitron delivers the treatment accurately and effectively.

MicroSelectron is a system used for multiple brachytherapy applications and is a predecessor of Flexitron. Esteya is electronic brachytherapy used for skin cancer treatment. Venezia is an applicator used in gynecological brachytherapy. Furthermore, in November 2020, Elekta announced Elekta Studio, a complete image-guided brachytherapy workflow in a single room. This would enhance the treatment efficiency and patient comfort.

New product launches and mergers and acquisitions are some of the major strategies adopted by the players to gain market share. For instance, in July 2022, BEBIG Medical successfully acquired Wolf-Medizintechnik GmbH (''WOmed'') to broaden its product offering in the field of radiation therapy for the treatment of cancer.

In January 2020, U. S. FDA approved GammaTile therapy for patients with stage I brain cancer. Isoray, Inc. and GT Medical Technology collaboratively developed GammaTile Therapy. According to Isoray, Inc., it is the only radiation therapy specifically designed for the treatment of the brain. The launch of such products over the coming years by market players is expected to accelerate growth.

Brachytherapy Market Report Highlights

  • The applicators & afterloaders segment dominated the brachytherapy industry and accounted for the largest revenue share of 44.5% in 2022. Applicators are more effective than others and are minimally intrusive, giving them a high level of patient preference
  • The prostate cancer segment accounted for the largest revenue share of 32.91% in 2022. The promising applications of internal radiation therapy in the treatment of prostate cancer are a major factor in the dominance of this segment
  • The HDR brachytherapy segment accounted for the largest revenue share of 71.5% in 2022. The various advantages of HDR internal radiation therapy such as short procedure time, protection from radiation exposure, and higher efficacy are key factors contributing to the dominance of this segment
  • Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to the presence of untapped opportunities in the emerging economies of China and India

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Dosage Type
1.1.1.2. Product
1.1.1.3. Application
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Dosage Type outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Brachytherapy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. The increasing prevalence of cancer
3.3.1.2. Technological advancements
3.3.2. Market restraint analysis
3.3.2.1. Lack of skilled radiotherapy professionals
3.4. Brachytherapy Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Brachytherapy: Dosage Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. High-Dose Rate (HDR)
4.1.2. Low-Dose Rate (LDR)
4.2. Dosage Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Brachytherapy Market by Dosage Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. High-Dose Rate (HDR)
4.5.1.1. HDR market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Low-Dose Rate (LDR)
4.5.2.1. LDR market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Brachytherapy: Product Estimates & Trend Analysis
5.1. Product Market Share, 2022 & 2030
5.2. Segment Dashboard
5.3. Global Brachytherapy Market by Material Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Seeds
5.4.1.1. Seeds market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Applicators & Afterloaders
5.4.2.1. Applicators & Afterloaders market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Electronic brachytherapy
5.4.3.1. Electronic brachytherapy market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Brachytherapy: Application Estimates & Trend Analysis
6.1. Application Market Share, 2022 & 2030
6.2. Segment Dashboard
6.3. Global Brachytherapy Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Prostrate
6.4.1.1. Prostrate market estimates and forecast 2018 to 2030 (USD Million)
6.4.2. Gynecological Cancer
6.4.2.1. Gynecological Cancer market estimates and forecast 2018 to 2030 (USD Million)
6.4.3. Breast
6.4.3.1. Breast management market estimates and forecast 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Brachytherapy Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2021
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. SWOT Analysis
7.7.2. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.3. U.S.
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.7.3.5. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.7.4. Canada
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. Regulatory Framework
7.7.4.5. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. SWOT Analysis
7.8.2. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.3. UK
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Competitive Scenario
7.8.3.4. Regulatory Framework
7.8.3.5. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.4. Germany
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Competitive Scenario
7.8.4.4. Regulatory Framework
7.8.4.5. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.5. France
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Competitive Scenario
7.8.5.4. Regulatory Framework
7.8.5.5. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.6. Italy
7.8.6.1. Key Country Dynamics
7.8.6.2. Target Disease Prevalence
7.8.6.3. Competitive Scenario
7.8.6.4. Regulatory Framework
7.8.6.5. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.7. Spain
7.8.7.1. Key Country Dynamics
7.8.7.2. Target Disease Prevalence
7.8.7.3. Competitive Scenario
7.8.7.4. Regulatory Framework
7.8.7.5. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.8. Denmark
7.8.8.1. Key Country Dynamics
7.8.8.2. Target Disease Prevalence
7.8.8.3. Competitive Scenario
7.8.8.4. Regulatory Framework
7.8.8.5. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.9. Sweden
7.8.9.1. Key Country Dynamics
7.8.9.2. Target Disease Prevalence
7.8.9.3. Competitive Scenario
7.8.9.4. Regulatory Framework
7.8.9.5. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.8.10. Norway
7.8.10.1. Key Country Dynamics
7.8.10.2. Target Disease Prevalence
7.8.10.3. Competitive Scenario
7.8.10.4. Regulatory Framework
7.8.10.5. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. SWOT Analysis
7.9.2. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.3. China
7.9.3.1. Key Country Dynamics
7.9.3.2. Target Disease Prevalence
7.9.3.3. Competitive Scenario
7.9.3.4. Regulatory Framework
7.9.3.5. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.4. Japan
7.9.4.1. Key Country Dynamics
7.9.4.2. Target Disease Prevalence
7.9.4.3. Competitive Scenario
7.9.4.4. Regulatory Framework
7.9.4.5. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
7.9.5. India
7.9.5.1. Key Country Dynamics
7.9.5.2. Target Disease Prevalence
7.9.5.3. Competitive Scenario
7.9.5.4. Regulatory Framework
7.9.5.5. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.6. Australia
7.9.6.1. Key Country Dynamics
7.9.6.2. Target Disease Prevalence
7.9.6.3. Competitive Scenario
7.9.6.4. Regulatory Framework
7.9.6.5. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.7. Thailand
7.9.7.1. Key Country Dynamics
7.9.7.2. Target Disease Prevalence
7.9.7.3. Competitive Scenario
7.9.7.4. Regulatory Framework
7.9.7.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.9.8. South Korea
7.9.8.1. Key Country Dynamics
7.9.8.2. Target Disease Prevalence
7.9.8.3. Competitive Scenario
7.9.8.4. Regulatory Framework
7.9.8.5. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. SWOT Analysis
7.10.2. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.3. Brazil
7.10.3.1. Key Country Dynamics
7.10.3.2. Target Disease Prevalence
7.10.3.3. Competitive Scenario
7.10.3.4. Regulatory Framework
7.10.3.5. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.4. Mexico
7.10.4.1. Key Country Dynamics
7.10.4.2. Target Disease Prevalence
7.10.4.3. Competitive Scenario
7.10.4.4. Regulatory Framework
7.10.4.5. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.10.5. Argentina
7.10.5.1. Key Country Dynamics
7.10.5.2. Target Disease Prevalence
7.10.5.3. Competitive Scenario
7.10.5.4. Regulatory Framework
7.10.5.5. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11. MEA
7.11.1. SWOT Analysis
7.11.2. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Key Country Dynamics
7.11.3.2. Target Disease Prevalence
7.11.3.3. Competitive Scenario
7.11.3.4. Regulatory Framework
7.11.3.5. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.4. South Africa
7.11.4.1. Key Country Dynamics
7.11.4.2. Target Disease Prevalence
7.11.4.3. Competitive Scenario
7.11.4.4. Regulatory Framework
7.11.4.5. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.5. UAE
7.11.5.1. Key Country Dynamics
7.11.5.2. Target Disease Prevalence
7.11.5.3. Competitive Scenario
7.11.5.4. Regulatory Framework
7.11.5.5. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.11.6. Kuwait
7.11.6.1. Key Country Dynamics
7.11.6.2. Target Disease Prevalence
7.11.6.3. Competitive Scenario
7.11.6.4. Regulatory Framework
7.11.6.5. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. ECKERT & ZIEGLER BEBIG
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. ISORAY MEDICAL, INC.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. ELEKTA AB
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. THERAGENICS
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Becton, Dickinson, and Company
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. CIVCO MEDICAL SOLUTIONS
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. SUN NUCLEAR CORPORATION
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. ICAD, INC.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. VARIAN MEDICAL SYSTEMS, INC.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 3 North America brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 4 North America brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 5 North America brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 7 U.S. brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 9 Canada brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 10 Canada brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 11 Canada brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 12 Europe brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 13 Europe brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 14 Europe brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 15 Europe brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 16 Germany brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 17 Germany brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 18 Germany brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 19 UK brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 20 UK brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 21 UK brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 22 France brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 23 France brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 24 France brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 25 Italy brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 26 Italy brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 27 Italy brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 28 Spain brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 29 Spain brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 30 Spain brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 31 Denmark brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 32 Denmark brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 33 Denmark brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 34 Sweden brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 35 Sweden brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 36 Sweden brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 37 Norway brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 38 Norway brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 39 Norway brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 40 Asia Pacific brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 44 China brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 45 China brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 46 China brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 47 Japan brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 48 Japan brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 49 Japan brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 50 India brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 51 India brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 52 India brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 53 South Korea brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 54 South Korea brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 55 South Korea brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 56 Australia brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 57 Australia brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 58 Australia brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 59 Thailand brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 60 Thailand brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 63 Latin America brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 67 Brazil brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 68 Brazil brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 69 Mexico brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 70 Mexico brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 71 Mexico brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 72 Argentina brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 73 Argentina brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 80 South Africa brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 85 UAE brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 86 UAE brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 87 UAE brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 88 Kuwait brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 89 Kuwait brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait brachytherapy market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Brachytherapy: market outlook
Fig. 9 Brachytherapy competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Brachytherapy market driver impact
Fig. 13 Brachytherapy market restraint impact
Fig. 14 Brachytherapy market strategic initiatives analysis
Fig. 15 Brachytherapy market: dosage type movement analysis
Fig. 16 Brachytherapy market: dosage type outlook and key takeaways
Fig. 17 HDR market estimates and forecasts, 2018 - 2030
Fig. 18 LDR market estimates and forecasts, 2018 - 2030
Fig. 19 Brachytherapy market: product movement analysis
Fig. 20 Brachytherapy market: product outlook and key takeaways
Fig. 21 Seeds market estimates and forecasts, 2018 - 2030
Fig. 22 Applicators & Afterloaders market estimates and forecasts, 2018 - 2030
Fig. 23 Electronic Brachytherapy market estimates and forecasts, 2018 - 2030
Fig. 24 Brachytherapy market: application movement analysis
Fig. 25 Brachytherapy market: application outlook and key takeaways
Fig. 26 Prostate cancer market estimates and forecasts, 2018 - 2030
Fig. 27 Gynecological cancer market estimates and forecast, 2018 - 2030
Fig. 28 Breast cancer market estimates and forecasts, 2018 - 2030
Fig. 29 Others market estimates and forecast, 2018 - 2030
Fig. 30 Global Brachytherapy market: regional movement analysis
Fig. 31 Global Brachytherapy market: regional outlook and key takeaways
Fig. 32 Global market share and leading players
Fig. 33 North America market share and leading players
Fig. 34 Europe market share and leading players
Fig. 35 Asia Pacific market share and leading players
Fig. 36 Latin America market share and leading players
Fig. 37 Middle East & Africa market share and leading players
Fig. 38 North America: SWOT
Fig. 39 Europe SWOT
Fig. 40 Asia Pacific SWOT
Fig. 41 Latin America SWOT
Fig. 42 MEA SWOT
Fig. 43 North America, by country
Fig. 44 North America
Fig. 45 North America market estimates and forecast, 2018 - 2030
Fig. 46 U.S. Key Country Dynamics
Fig. 47 U.S. market estimates and forecast, 2018 - 2030
Fig. 48 Canada Key Country Dynamics
Fig. 49 Canada market estimates and forecast, 2018 - 2030
Fig. 50 Europe
Fig. 51 Europe. market estimates and forecast, 2018 - 2030
Fig. 52 UK Key Country Dynamics
Fig. 53 UK market estimates and forecast, 2018 - 2030
Fig. 54 Germany Key Country Dynamics
Fig. 55 Germany market estimates and forecast, 2018 - 2030
Fig. 56 France Key Country Dynamics
Fig. 57 France market estimates and forecast, 2018 - 2030
Fig. 58 Italy Key Country Dynamics
Fig. 59 Italy market estimates and forecast, 2018 - 2030
Fig. 60 Spain Key Country Dynamics
Fig. 61 Spain market estimates and forecast, 2018 - 2030
Fig. 62 Sweden Key Country Dynamics
Fig. 63 Sweden market estimates and forecast, 2018 - 2030
Fig. 64 Norway Key Country Dynamics
Fig. 65 Norway market estimates and forecast, 2018 - 2030
Fig. 66 Denmark Key Country Dynamics
Fig. 67 Denmark market estimates and forecast, 2018 - 2030
Fig. 68 Asia Pacific
Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 70 China Key Country Dynamics
Fig. 71 China market estimates and forecast, 2018 - 2030
Fig. 72 Japan Key Country Dynamics
Fig. 73 Japan market estimates and forecast, 2018 - 2030
Fig. 74 India Key Country Dynamics
Fig. 75 India market estimates and forecast, 2018 - 2030
Fig. 76 Australia Key Country Dynamics
Fig. 77 Australia market estimates and forecast, 2018 - 2030
Fig. 78 Thailand Key Country Dynamics
Fig. 79 Thailand market estimates and forecast, 2018 - 2030
Fig. 80 South Korea Key Country Dynamics
Fig. 81 South Korea market estimates and forecast, 2018 - 2030
Fig. 82 Latin America Key Country Dynamics
Fig. 83 Latin America market estimates and forecast, 2018 - 2030
Fig. 84 Brazil Key Country Dynamics
Fig. 85 Brazil market estimates and forecast, 2018 - 2030
Fig. 86 Mexico Key Country Dynamics
Fig. 87 Mexico market estimates and forecast, 2018 - 2030
Fig. 88 Argentina Key Country Dynamics
Fig. 89 Argentina market estimates and forecast, 2018 - 2030
Fig. 90 Middle East and Africa
Fig. 91 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 92 Saudi Arabia Key Country Dynamics
Fig. 93 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 94 South Africa Key Country Dynamics
Fig. 95 South Africa market estimates and forecast, 2018 - 2030
Fig. 96 UAE Key Country Dynamics
Fig. 97 UAE market estimates and forecast, 2018 - 2030
Fig. 98 Kuwait Key Country Dynamics
Fig. 99 Kuwait market estimates and forecast, 2018 - 2030
Fig. 100 Participant categorization - Brachytherapy market
Fig. 101 Market share of key market players - Brachytherapy market

Companies Mentioned

  • ECKERT & ZIEGLER BEBIG
  • ISORAY MEDICAL, INC.
  • ELEKTA AB
  • THERAGENICS
  • Becton, Dickinson, and Company
  • CIVCO MEDICAL SOLUTIONS
  • SUN NUCLEAR CORPORATION
  • ICAD, INC.
  • VARIAN MEDICAL SYSTEMS, INC.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 907.76 Million
Forecasted Market Value ( USD ) by 2030 $ 1620 Million
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Brachytherapy Market by Indication, Offering, Dosage Type, End User - Global Forecast 2025-2030 - Product Image

Brachytherapy Market by Indication, Offering, Dosage Type, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Brachytherapy Devices Market by Product, Technique, Application, End-User - Global Forecast 2025-2030 - Product Image

Brachytherapy Devices Market by Product, Technique, Application, End-User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 170 Pages
  • Global
From
Brachytherapy Devices Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Type, Application, End User, and Geography - Product Image

Brachytherapy Devices Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Type, Application, End User, and Geography

  • Report
  • 150 Pages
  • Global
From
Brachytherapy Market Report 2024 - Product Image

Brachytherapy Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.